Welcome to our Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies around the...more
4/15/2026
/ Artificial Intelligence ,
Biotechnology ,
China ,
Clinical Trials ,
Compliance ,
Cross-Border ,
Data Protection ,
Due Diligence ,
Environmental Social & Governance (ESG) ,
European Commission ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
General Data Protection Regulation (GDPR) ,
Government Agencies ,
Health Care Providers ,
Healthcare ,
Life Sciences ,
Medical Devices ,
Patent Infringement ,
Patent Litigation ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Agencies ,
Regulatory Oversight ,
Regulatory Reform ,
Regulatory Requirements ,
Risk Management ,
Unified Patent Court
The UPC has been reshaping European patent litigation since its launch in June 2023. More than 480 patents have now been litigated in the court, and the number of actions is steadily increasing. Initially, major...more
4/14/2026
/ Appeals ,
Claim Construction ,
EU ,
Healthcare ,
Intellectual Property Protection ,
Life Sciences ,
Medical Devices ,
Patent Infringement ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Preliminary Injunctions ,
Prior Art ,
Unified Patent Court
The UPC Court of Appeal has now provided clear guidance on how the UPC should determine whether a patent involves an inventive step. This endorses the “holistic” approach, establishing what the invention contributes to the...more
The UPC Court of Appeal (CA) has clarified the framework for penalty payments in enforcement proceedings. Penalty payments in the UPC must be based on a prior penalty order from the court, specifically reinforced with the...more
11/12/2025
/ Appeals ,
Appellate Courts ,
Case Management ,
Enforcement Actions ,
EU ,
European Patent Convention ,
Germany ,
Injunctions ,
Intellectual Property Litigation ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Penalties ,
Statutory Interpretation ,
Unified Patent Court
The Unified Patent Court (UPC) has given an important ruling confirming its “long-arm jurisdiction”, with important consequences for the UK. The Mannheim Local Division (LD) confirmed in Fujifilm v. Kodak that it could hear...more
The UPC Court of Appeal (the CoA) has issued a significant judgment in Koninklijke Philips v. Belkin clarifying the scope of directors’ liability. The court also confirmed the availability of corrective measures such as...more
This case concerns infringement by Glenmark on Novartis’ SPC 300451 for eltrombopag (marketed as Revolade®). Novartis sought urgent relief after Glenmark included its generic "Eltrombopag Glenmark" product in the Dutch...more
Welcome to our inaugural Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies...more
9/18/2025
/ Artificial Intelligence ,
Biologics ,
Compliance ,
Cybersecurity ,
Data Privacy ,
Generic Drugs ,
Health Care Providers ,
Healthcare ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Requirements
In a landmark ruling the UPC Court of Appeal has for the first time in the pharmaceutical sector granted a provisional injunction for imminent patent infringement, clarifying that completing administrative procedures for...more
UPC case law on the assessment of inventive step is still evolving. Most local division (LD) decisions have indicated a slightly diverging practice from the EPO’s problem-solution approach. However, more recently, others have...more
Patent holders must start Unified Patent Court (UPC) proceedings on the merits within a certain period if they do not want to risk the revocation of provisional measures. The UPC has now clarified that filing the statement of...more
4/11/2025
/ Appeals ,
Deadlines ,
European Commission ,
Filing Deadlines ,
Germany ,
Litigation Strategies ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Unified Patent Court
Ortovox Sportartikel GmbH v. Mammut Sports Group AG/GmbH (UPC_CFI_16/2024), Düsseldorf Local Division (January 14, 2025) ORD_63219/2024.
Anyone developing or marketing an innovative product will want to ensure that they do...more
In a landmark decision Fives ECL, SAS v. REEL GmbH on January 16, 2025, the Court of Appeal (CoA) of the Unified Patent Court (UPC) clarified the jurisdictional boundaries of the UPC. This decision has far-reaching...more
4/2/2025
/ Appeals ,
Damages ,
EU ,
Germany ,
Intellectual Property Protection ,
Jurisdiction ,
Member State ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Unified Patent Court
In this note, we will discuss the latest decisions on the merits from the Dutch patent court on the matter of plausibility and inventive step. These were handed down in two cases (BMS v Sandoz and BMS v Teva) on 30 October...more
11/15/2024
/ Appeals ,
EU ,
Inventions ,
Netherlands ,
Patent Applications ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Technology ,
Teva v Sandoz ,
Unified Patent Court
Today marked a ‘historic moment’ for the UPC, as Klaus Gabrinsky, the President of the UPC Court of Appeal, noted in his opening remarks: the first UPC Court of Appeal hearing, on 18 December 2023 in Luxembourg.
The case...more
On 18 October 2023, the President of the Court of First Instance of the UPC issued an order changing the procedural language from Dutch to English (the language of the patent at issue).
The Court weighed the interests of...more
In this episode of our Exclusively Life Sciences webinar series, our experts from our EU team will share best practices for innovators to protect their competitive advantage when generics enter the market....more
In our latest blogpost of 20 January 2022, we discussed the kick-off to the preparatory phase for the actual start of the Unified Patent Court (UPC). We are now one step closer to the actual start: on 8 July, the...more
Last Friday 17 June 2022, the WTO member states came to an agreement on the long negotiated TRIPS Waiver. In its annual 6 days conference (the Ministerial Conference), the WTO member states agreed that all developing country...more
Last month, a leaked document regarding the TRIPS Waiver revealed a breakthrough between the EU, South Africa, India and the United States. After 18 months of negotiations, the four parties now have reached a high-level...more
The entire privacy community waited anxiously for the outcome of the EUR 11 billion class action claim, launched in the summer of 2020 by The Privacy Collective (TPC) against several Oracle and Salesforce entities at the...more
On 2 October 2020, South Africa and India submitted a proposal to the WTO to temporarily suspend certain provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). In short, the...more
On 15 December 2020, the European Commission published its Digital Services Act package which proposes two pieces of legislation: the Digital Services Act and the Digital Markets Act. This package will profoundly change the...more
Today the 27 member states of the European Union have decided on Amsterdam as the new home of the European Medicines Agency. The decision came after three rounds of voting, with Amsterdam eventually emerging the winner after...more
Further changes to the EU Trade Mark (“EUTM”) system come into effect on 1 October 2017. These are the next step in the EU’s trade mark reforms, which are aimed at modernising the system to make it technologically up-to-date...more